We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+21.84%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$6.11B
AUM Growth
-$283M
Cap. Flow
-$874M
Cap. Flow %
-14.3%
Top 10 Hldgs %
62.65%
Holding
207
New
52
Increased
29
Reduced
48
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Financials 4.76%
3 Healthcare 4.33%
4 Utilities 3.73%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TW icon
126
Tradeweb Markets
TW
$21.8B
$464K 0.01%
+10,000
New +$431K
NET icon
127
Cloudflare
NET
$107B
$427K 0.01%
25,000
ELAN icon
128
Elanco Animal Health
ELAN
$11.8B
$426K 0.01%
14,480
CMBM
129
DELISTED
Cambium Networks
CMBM
$393K 0.01%
45,000
-54,600
-55% -$423K
INSP icon
130
Inspire Medical Systems
INSP
$1.73B
$371K 0.01%
5,000
-7,500
-60% -$482K
CFB
131
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$361K 0.01%
25,000
CRWD icon
132
CrowdStrike
CRWD
$215B
$299K ﹤0.01%
+24,000
New +$315K
AAL icon
133
CALL
American Airlines Group
AAL
$10.5B
$287K ﹤0.01%
10,000
NXTC icon
134
NextCure
NXTC
$21.9M
$282K ﹤0.01%
+417
New +$209K
MEC icon
135
Mayville Engineering Co
MEC
$614M
$281K ﹤0.01%
30,000
-30,000
-50% -$311K
EVOP
136
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$264K ﹤0.01%
10,000
-9,800
-49% -$270K
OYST
137
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$254K ﹤0.01%
+10,400
New +$183K
ENDP
138
DELISTED
Endo International plc
ENDP
$235K ﹤0.01%
50,000
-330,000
-87% -$1.47M
PTON icon
139
Peloton Interactive
PTON
$2.46B
$227K ﹤0.01%
8,000
-2,000
-20% -$53.9K
AXNX
140
DELISTED
Axonics, Inc. Common Stock
AXNX
$222K ﹤0.01%
+8,000
New +$191K
SWAV
141
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$220K ﹤0.01%
5,000
-5,000
-50% -$185K
I
142
CALL
DELISTED
INTELSAT S. A.
I
$211K ﹤0.01%
30,000
-270,000
-90% -$4.24M
PHR icon
143
Phreesia
PHR
$789M
$200K ﹤0.01%
+7,500
New +$207K
NGM
144
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$185K ﹤0.01%
10,000
-9,100
-48% -$133K
GDS icon
145
GDS Holdings
GDS
$6.44B
$181K ﹤0.01%
+3,500
New +$157K
GSL icon
146
Global Ship Lease
GSL
$1.51B
$150K ﹤0.01%
17,000
-16,055
-49% -$128K
ABBV icon
147
AbbVie
ABBV
$433B
$99K ﹤0.01%
+1,113
New +$92.4K
ALEC icon
148
Alector
ALEC
$212M
$48K ﹤0.01%
+2,800
New +$47.6K
AGFSW
149
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$2K ﹤0.01%
242,331
AAL icon
150
PUT
American Airlines Group
AAL
$10.5B
-157,500
Closed -$4.25M

Similar funds

Pentwater Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Pentwater Capital Management held 207 positions worth $6.11B, down 4.4% from $6.4B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Pentwater Capital Management withdrew a net $874M in Q4 2019, closing 56 positions and reducing 48 holdings. Its most notable exit was Celgene Corp, an estimated $615M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pentwater Capital Management opened a new position in TD Ameritrade Holding Corp worth $253M.

  • Pentwater Capital Management's largest Q4 2019 buy was TD Ameritrade Holding Corp: 5,089,000 shares worth $253M.
  • Pentwater Capital Management added most to PG&E in Q4 2019, an estimated $105M increase.
  • Pentwater Capital Management's biggest Q4 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $122M.
  • Pentwater Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $615M.
  • Pentwater Capital Management's ten largest holdings make up 63% of its $6.11B portfolio in Q4 2019.
  • Pentwater Capital Management opened 52 new positions and closed 56 in Q4 2019.
  • Pentwater Capital Management's portfolio value fell 4.4% quarter-over-quarter to $6.11B.

Based on Pentwater Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.